AI-Driven Cardiac Ablation System with Adaptive Flexible Circuits

A next-generation cardiac ablation system integrating AI-driven algorithms, self-healing materials, and nanoscale sensors to revolutionize cardiac arrhythmia treatment.

The original patent disclosed a flexible circuit for use with a catheter, addressing the need for improved electrophysiology catheters in cardiac arrhythmia treatment. However, the current technology has limitations in adapting to real-time cardiac tissue changes and minimizing thermal damage to surrounding tissue during ablation procedures. The new inventive concept addresses these limitations by introducing AI-driven ablation algorithms, self-healing insulative materials, and nanoscale sensors to enhance the precision and safety of cardiac ablation.

The AI-driven cardiac ablation system comprises a flexible circuit with an integrated AI-driven ablation algorithm that adapts to real-time cardiac tissue changes during an ablation procedure. The flexible circuit is designed with a self-healing insulative material to minimize thermal damage to surrounding tissue during ablation. Additionally, the system incorporates a nanoscale sensor array capable of detecting and analyzing electrical signals at the molecular level, enabling precise mapping and ablation of cardiac tissue. The system can be further enhanced with a shape-memory alloy that conforms to the complex geometry of cardiac tissue, ensuring precise ablation. The metamaterial-based insulator dynamically adjusts its thermal conductivity in response to changing ablation conditions, optimizing the ablation process.

The new inventive concept introduces a paradigm shift in cardiac ablation technology by integrating AI-driven algorithms, self-healing materials, and nanoscale sensors, which are not present in the original patent. The AI-driven ablation algorithm, self-healing insulative material, and nanoscale sensor array provide a novel and non-obvious solution to the limitations of current cardiac ablation technology.

Alternative embodiments of the inventive concept could include using different AI-driven algorithms, such as machine learning or deep learning, to optimize the ablation process. Variations could also include integrating the flexible circuit with other medical devices, such as ultrasound or MRI systems, to enhance the precision of cardiac ablation.

The AI-driven cardiac ablation system has significant commercial potential in the medical device industry, particularly in the cardiac arrhythmia treatment market. The system could be marketed to hospitals, clinics, and medical research institutions, offering a next-generation solution for cardiac arrhythmia treatment.